Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict

American Heart Journal

Volumn 155, Issue 5, 2008, Pages 841-847

  Chew, Derek P ^a   Mahaffey, Kenneth W ^b   White, Harvey D ^c   Huang, Zhen ^b   Hoekstra, James W ^d   Ferguson, James J ^e   Califf, Robert M ^b   Aylward, Philip E ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DATA BASE; DEMOGRAPHY; FATALITY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION;

EID: 43049150433     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.12.002     Document Type: Article

References (16)

1. C.P. Cannon W.S. Weintraub L.A. Demopoulos Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887
2. P.G. Steg R.J. Goldberg J.M. Gore Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE) Am J Cardiol 90 2002 358 363
3. J.J. Ferguson R.M. Califf E.M. Antman Enoxaparin vs unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial JAMA 292 2004 45 54
4. E. Braunwald E.M. Antman J.W. Beasley ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 40 2002 1366 1374
5. M.J. Lim K.A. Eagle J.M. Gore Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events) Am J Cardiol 96 2005 917 921
6. K.W. Mahaffey M. Cohen J. Garg High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial JAMA 294 2005 2594 2600
7. S.V. Rao K. O'Grady K.S. Pieper A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes J Am Coll Cardiol 47 2006 809 816
8. A.K. Rao C. Pratt A. Berke Thrombolysis in Myocardial Infarction (TIMI) Trial—phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11
9. C.S. Landefeld E.F. Cook M. Flatley Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy Am J Med 82 1987 703 713
10. G.W. Stone B.T. McLaurin D.A. Cox Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
11. R.H. Mehta A.Y. Chen C.V. Pollack Jr Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non–ST-segment elevation acute coronary syndromes Am J Cardiol 98 2006 624 627
12. S.P. Marso D.L. Bhatt M.T. Roe Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators Circulation 102 2000 2952 2958
13. D.P. Chew D.L. Bhatt A.M. Lincoff Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk Heart 92 2006 945 950
14. R.H. Mehta M.T. Roe J. Mulgund Acute clopidogrel use and outcomes in patients with non–ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery J Am Coll Cardiol 48 2006 281 286
15. P. Kaul L.K. Newby Y. Fu Relation between baseline risk and treatment decisions in non–ST elevation acute coronary syndromes: an examination of international practice patterns Heart 91 2005 876 881
16. S. Garcia M.J. Canoniero J.A. Chirinos Development of a score to predict the need for coronary artery bypass graft surgery in patients with non–ST segment elevation acute coronary syndromes Ann Thorac Surg 78 2004 2022 2026 [discussion 6-7]